Concepedia

Sheila Garman

SG

Statistics

Publications

4

Citations

733

H-Index

4

Active since

1999

Affiliations

Novartis (Switzerland)(Current)

Sheila Garman is an author at Novartis (Switzerland) specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

1999–2010

4

Publications

4

4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2<i>H</i>-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1

Keith Menear, Claire Adcock, Robert Boulter et al. · Journal of Medicinal Chemistry · 2008 · 586 citations · Full text

, , +16

The Identification of Indacaterol as an Ultralong-Acting Inhaled β<sub>2</sub>-Adrenoceptor Agonist

François Baur, David T. Beattie, David Beer et al. · Journal of Medicinal Chemistry · 2010 · 104 citations · Full text

, , +14

Design and Synthesis of Thrombin Inhibitors:  Analogues of MD-805 with Reduced Stereogenicity and Improved Potency

Derek E. Brundish, Alice Bull, Vera Donovan et al. · Journal of Medicinal Chemistry · 1999 · 30 citations · Full text

, , +14

The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position

Urs Baettig, Lyndon Brown, Derek E. Brundish et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 13 citations · Full text

, , +14

1–4 of 4